Jeremy Whannell is a journalist who writes for Born2Invest, covering topics related to finance, sustainability, and innovation. With a focus on ESG (Environmental, Social, and Governance) reporting, Jeremy explores the intersection of business and sustainability, highlighting initiatives and investments that promote a circular economy and ecological transition.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Jeremy's coverage is focused on investment, sustainability, and renewable energy within the context of business and industry. His articles include a blend of press releases, data citations, announcements, and private sector news.
Given Jeremy's emphasis on sustainability in finance and industry sectors across various countries in Europe, he would likely be receptive to pitches related to innovative sustainable initiatives or investments with genuine ESG (Environmental Social Governance) impacts. Consider offering expert insights into emerging trends in ESG investing or specific case studies that demonstrate the tangible benefits of green taxation or transition finance for businesses.
Suggesting topics related to pension plans' trust in restarting ESG investing or highlighting successful examples of sustainable projects within the real estate industry could also capture Jeremy's interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jeremy Whannell
PlanRadar, a platform for digital documentation in construction, facility management, and real estate, found that only a third of industry professionals believe in the benefits of digital tools for ESG certification. However, PlanRadar customers report significant advantages, indicating untapped potential. With ESG investments predicted to reach $33.9 trillion by 2026, adopting digital platforms could offer competitive advantages. 0 SHARES
By: Jeremy Whannell
Recoletas Salud has transformed €283 million in financing into a sustainable operation coordinated by ING. This initiative commits the hospital group to green and socially responsible practices, including reducing its carbon footprint, increasing renewable energy use, boosting research and development, and enhancing employee training. The transformation aligns with major objectives of the 2030 Agenda for Sustainable Development. 0 SHARES
The Lifebility Award, in its 14th edition, supports young founders under 35 with projects aimed at positively impacting lives. Beyond financial support, winners receive ongoing mentorship to scale their ideas into businesses. Supported by the Lions Association, the initiative has produced global successes. This year’s winners, ARGO, AI Vs Linfomi, and RigeneraDermo, exemplify youth-driven societal change.
The CSRD is more than just a reporting requirement; it is a milestone in the fundamental change in the economy.
Spanish companies face challenges with the new European Directive on sustainability, as many lack sufficient technological implementation.
NextPower UK (NPUK) raised capital from investors including London LGPS CIV, various UK pension funds, and international investors, with the UK Infrastructure Bank contributing £250 million. Over 75% of NPUK’s capacity is operational or under construction, with dividends surpassing expectations. NPUK focuses on solar and battery storage assets, achieving significant growth.
Eco-Techno, through Itago IV fund, acquired Scae and Enviro Solutions, bolstering its industrial liquid waste treatment sector presence.
Huma Therapeutics Limited has completed a Series D funding round and is now ready to launch the Huma Cloud platform with GenAI integrations
Illuminem, a Venetian startup founded by Andrea Gori, secured €2 million in funding from international venture capital firms and climate leaders. Valued at €12 million, Illuminem uses AI to find valuable climate content, helps sustainability solution providers grow, and monitors ESG performance. The company has a vast network of climate experts and won second place in a Community Award.
Sartorius Stedim Biotech reported a slight revenue decrease and significant drops in net profit and EBITDA for the first half of 2024, leading to a cautious outlook and adjusted financial forecast. The company anticipates improved effects from cost reduction programs but lowered its EBITDA margin expectations and revised its investment and debt ratio objectives through to 2028. 0 SHARES
(833) 317-6278 
